Literature DB >> 2086735

Effects of 131I-EGF on cultured human glioma cells.

J Capala1, M Pråhl, S Scott-Robson, J Pontén, B Westermark, J Carlsson.   

Abstract

Malignant glioma cells often have more epidermal growth factor (EGF) receptors than normal cells and targeting of toxic substances to the receptor might therefore be an attractive therapeutical approach. Radiation effects were analysed on human glioma cells growing as monolayers after exposure to 131I-EGF. Unspecific effects were analysed with 131I-BSA or after presaturation with nonradioactive EGF. The radiation effects were compared to the effects obtained by external 60Co gamma irradiation. Administration of the highest radioactive concentrations, 0.2-0.5 MBq/ml in the culture medium, corresponded, after 20 min incubation, to a binding of about 1.0-2.5 dpm/cell. Such an exposure to 131I decays gave effects on cell survival corresponding to about 2.5 Gy of external gamma irradiation. Somewhat less than half of this effect came from the specific bound radioactivity and the rest from nonbound radioactivity. When administrating lower concentrations of radioactivity both the binding and the radiation effects were smaller. The observations showed that it is possible to inactivate cell-proliferation of glioma cells with specific bound 131I-EGF. The possibilities to fractionate the treatments and of binding also other toxic agents than 131I to the EGF receptor are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2086735     DOI: 10.1007/BF02341150

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  38 in total

Review 1.  Epidermal growth factor: the receptor and its function.

Authors:  G Todderud; G Carpenter
Journal:  Biofactors       Date:  1989-03       Impact factor: 6.113

2.  Computer programs for the analysis of cellular survival data.

Authors:  N Albright
Journal:  Radiat Res       Date:  1987-11       Impact factor: 2.841

3.  Survival of irradiated glia and glioma cells studied with a new cloning technique.

Authors:  S Nilsson; J Carlsson; B Larsson; J Ponten
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1980-03

4.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

Authors:  T A Libermann; H R Nusbaum; N Razon; R Kris; I Lax; H Soreq; N Whittle; M D Waterfield; A Ullrich; J Schlessinger
Journal:  Nature       Date:  1985 Jan 10-18       Impact factor: 49.962

5.  Epidermal growth factor receptor expression and growth fraction in human tumours of the nervous system.

Authors:  G Reifenberger; R Prior; M Deckert; W Wechsler
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

6.  131I-anticarcinoembryonic antigen therapy of LS174T human colon adenocarcinoma spheroids.

Authors:  V K Langmuir; J K McGann; F Buchegger; R M Sutherland
Journal:  Cancer Res       Date:  1989-06-15       Impact factor: 12.701

7.  Toxicity of ligand and antibody-directed ricin A-chain conjugates recognizing the epidermal growth factor receptor.

Authors:  A M Vollmar; D E Banker; J Mendelsohn; H R Herschman
Journal:  J Cell Physiol       Date:  1987-06       Impact factor: 6.384

Review 8.  Structural basis for epidermal growth factor receptor function.

Authors:  J J Hsuan; G Panayotou; M D Waterfield
Journal:  Prog Growth Factor Res       Date:  1989

Review 9.  The solution structures of epidermal growth factor and transforming growth factor alpha.

Authors:  I D Campbell; R M Cooke; M Baron; T S Harvey; M J Tappin
Journal:  Prog Growth Factor Res       Date:  1989

10.  125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts.

Authors:  G Carpenter; S Cohen
Journal:  J Cell Biol       Date:  1976-10       Impact factor: 10.539

View more
  4 in total

Review 1.  Planning for intracavitary anti-EGFR radionuclide therapy of gliomas. Literature review and data on EGFR expression.

Authors:  J Carlsson; Z P Ren; K Wester; A L Sundberg; N E Heldin; G Hesselager; M Persson; L Gedda; V Tolmachev; H Lundqvist; E Blomquist; M Nistér
Journal:  J Neurooncol       Date:  2006-03       Impact factor: 4.130

2.  HER2- and EGFR-specific affiprobes: novel recombinant optical probes for cell imaging.

Authors:  Ilya Lyakhov; Rafal Zielinski; Monika Kuban; Gabriela Kramer-Marek; Robert Fisher; Oleg Chertov; Lakshman Bindu; Jacek Capala
Journal:  Chembiochem       Date:  2010-02-15       Impact factor: 3.164

3.  Combined effect of gefitinib ('Iressa', ZD1839) and targeted radiotherapy with 211At-EGF.

Authors:  Asa Liljegren Sundberg; Ylva Almqvist; Anna Orlova; Erik Blomquist; Holger J Jensen; Lars Gedda; Vladimir Tolmachev; Jörgen Carlsson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-08-21       Impact factor: 9.236

4.  Effects of EGF-dextran-tyrosine-131I conjugates on the clonogenic survival of cultured glioma cells.

Authors:  A Andersson; J Capala; J Carlsson
Journal:  J Neurooncol       Date:  1992-11       Impact factor: 4.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.